PDB3 SGLT2 Inhibitors and Risk of Diabetic Ketoacidosis in Patients with Type 2 Diabetes: Systematic Review and Meta-Analysis of Randomized Controlled Trials
2020 ◽
Vol 22
(9)
◽
pp. 1619-1627
◽
2020 ◽
2020 ◽
2020 ◽
2020 ◽
2020 ◽
2020 ◽
2020 ◽
2020 ◽